Casciano Anthony 4
4 · AMAG PHARMACEUTICALS INC. · Filed Apr 5, 2019
Insider Transaction Report
Form 4
Casciano Anthony
Chief Commercial Officer
Transactions
- Award
Common Stock
2019-04-04+15,000→ 60,852 total - Award
Stock Option (Right to Buy)
2019-04-04+25,000→ 25,000 totalExercise: $13.03Exp: 2029-04-04→ Common Stock (25,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer").
- [F2]These shares of Common Stock are issuable pursuant to a grant of RSUs pursuant to the Issuer's Fourth Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest in three equal annual installments with the first installment vesting on April 4, 2020.
- [F3]Not applicable.
- [F4]Grant of stock option pursuant to the Plan. This option will vest and become exercisable over four years after the grant date as follows: (i) 25% on the first anniversary of the grant date and (ii) the balance vesting in equal quarterly installments over the next three years thereafter.